CRM1 expression in matched tumor and normal tissues obtained from 43 laryngeal cancer patients were evaluated intracellular for protein and mRNA levels by immunohistochemical staining (IHC), western-blot, and quantitative real–time RT-PCR (qRT-PCR), respectively. This evidence concerns the gene XPO1 and neoplasm.